Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

计划入组 10 人 · 首次发布于 2013 年 1 月 25 日

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

计划入组 50 人 · 首次发布于 2008 年 7 月 15 日

Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)

计划入组 11 人 · 首次发布于 2017 年 10 月 27 日

Temsirolimus(Torisel)

C₅₆H₈₇NO₁₆

renal cell carcinoma program

Tivozanib(Fotivda)

C₂₂H₁₉ClN₄O₅ · Rx

RCC MEDICAL SUPPLY, INC.

United States

River 3 Renal Corp.

United States

Southeast Renal Research Institute

United States

Advances and Challenges in Renal Cell Carcinoma Treatment

Evolving Treatment Landscape in Advanced Clear Cell Renal Cell Carcinoma Highlighted in Recent Clinical Trials

Allogene's ALLO-316 Receives FDA RMAT Designation for Advanced Renal Cell Carcinoma